BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28062257)

  • 1. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
    Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide ameliorates cognitive decline by promoting autophagy via the AMP-activated protein kinase/mammalian target of rapamycin pathway in a streptozotocin-induced mouse model of diabetes.
    Kong FJ; Wu JH; Sun SY; Ma LL; Zhou JQ
    Neuropharmacology; 2018 Mar; 131():316-325. PubMed ID: 29305122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
    Yan W; Pang M; Yu Y; Gou X; Si P; Zhawatibai A; Zhang Y; Zhang M; Guo T; Yi X; Chen L
    Life Sci; 2019 Aug; 231():116566. PubMed ID: 31201846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.
    Citraro R; Iannone M; Leo A; De Caro C; Nesci V; Tallarico M; Abdalla K; Palma E; Arturi F; De Sarro G; Constanti A; Russo E
    Brain Res Bull; 2019 Nov; 153():133-142. PubMed ID: 31470253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in TNF alpha and oxidative stress by liraglutide: Impact on ketamine-induced cognitive dysfunction and hyperlocomotion in rats.
    Sedky AA; Magdy Y
    Life Sci; 2021 Aug; 278():119523. PubMed ID: 33891942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline reverses diabetes-associated cognitive impairment in rats.
    Mehta BK; Banerjee S
    Pharmacol Rep; 2019 Aug; 71(4):713-720. PubMed ID: 31207433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome.
    Saad MA; Eltarzy MA; Abdel Salam RM; Ahmed MAE
    Life Sci; 2021 Jan; 265():118731. PubMed ID: 33160995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice.
    Xiong H; Zheng C; Wang J; Song J; Zhao G; Shen H; Deng Y
    J Alzheimers Dis; 2013; 37(3):623-35. PubMed ID: 24008687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
    Shi L; Zhang Z; Li L; Hölscher C
    Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
    J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
    Kamble M; Gupta R; Rehan HS; Gupta LK
    Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model.
    Cassano V; Leo A; Tallarico M; Nesci V; Cimellaro A; Fiorentino TV; Citraro R; Hribal ML; De Sarro G; Perticone F; Sesti G; Russo E; Sciacqua A
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32023991
    [No Abstract]   [Full Text] [Related]  

  • 13. Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia.
    Gocmez SS; Şahin TD; Yazir Y; Duruksu G; Eraldemir FC; Polat S; Utkan T
    Physiol Behav; 2019 Mar; 201():198-207. PubMed ID: 30550811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren and captopril improve cognitive deficits in poorly controlled STZ-induced diabetic rats via amelioration of the hippocampal P-ERK, GSK3β, P-GSK3β pathway.
    Youssef MM; Abd El-Latif HA; El-Yamany MF; Georgy GS
    Toxicol Appl Pharmacol; 2020 May; 394():114954. PubMed ID: 32171570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zeaxanthin improves diabetes-induced cognitive deficit in rats through activiting PI3K/AKT signaling pathway.
    Zhou X; Wang S; Ding X; Qin L; Mao Y; Chen L; Li W; Ying C
    Brain Res Bull; 2017 Jun; 132():190-198. PubMed ID: 28599877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide versus pramlintide in protecting against cognitive function impairment through affecting PI3K/AKT/GSK-3β/TTBK1 pathway and decreasing Tau hyperphosphorylation in high-fat diet- streptozocin rat model.
    Moghazy HM; Abdelhaliem NG; Mohammed SA; Hassan A; Abdelrahman A
    Pflugers Arch; 2024 May; 476(5):779-795. PubMed ID: 38536493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury.
    Bai B; Li D; Xue G; Feng P; Wang M; Han Y; Wang Y; Hölscher C
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):333-343. PubMed ID: 33500109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chrysophanol Relieves Cognition Deficits and Neuronal Loss Through Inhibition of Inflammation in Diabetic Mice.
    Chu X; Zhou S; Sun R; Wang L; Xing C; Liang R; Kong Q
    Neurochem Res; 2018 Apr; 43(4):972-983. PubMed ID: 29497904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin reverses cognitive deficits in streptozotocin-induced type 1 diabetes in the rat through attenuation of oxidative stress and inflammation.
    Albazal A; Delshad AA; Roghani M
    J Chem Neuroanat; 2021 Mar; 112():101902. PubMed ID: 33276072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.